Discover 999 paid clinical trials in Rochester, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 999
Kidney Precision Medicine Project
for
Acute Kidney Failure, Acute Kidney Insufficiency,
Location: Rochester MN, Minneapolis MN, Chicago IL, Cleveland OH,
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 18+
Code: NCT04334707
Recruiting
Optimizing Brain Stimulation Parameters
for
Epilepsy; Seizure
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 6+
Code: NCT06617845
Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Rochester MN, Madison WI, Iowa City IA, Milwaukee WI,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06638307
Phase 1, Recruiting
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma
for
Clinical Stage I Esophageal Adenocarcinoma AJCC v8,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06078709
Phase 2, Recruiting
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
for
Cirrhosis, Liver, Liver Fibrosis, Ascites Hepatic
Location: Rochester MN, Cleveland OH, Dallas TX, Philadelphia PA,
Sponsor: PharmaIN
Sex: All
Age: 18 - 70+
Code: NCT05490888
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
for
Bladder Carcinoma
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06891209
Recruiting
Stroke Thrombectomy and Aneurysm Registry
for
Stroke, Thromboses, Intracranial, Aneurysm, Brain
Location: Rochester MN, Iowa City IA, Evanston IL, Chicago IL,
Sponsor: Medical University of South Carolina
Sex: All
Age: 1 - 70+
Code: NCT04994756
Recruiting
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
Location: Rochester MN, Toronto, Montreal, New York NY,
Sponsor: Mayo Clinic
Sex: All
Age: 0+
Code: NCT06689956
Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
for
Relapsed Hematologic Malignancy,
Location: Rochester MN, Omaha NE, Chicago IL, Cleveland OH,
Sponsor: Curis, Inc.
Sex: All
Age: 18+
Code: NCT03328078
Phase 1, Phase 2, Recruiting
Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
for
Bone Sarcoma, Chondrosarcoma, Chordoma, Ewing Sarcoma of Bone,
Location: Rochester MN, Jacksonville FL, Scottsdale AZ
Sponsor: Mayo Clinic
Sex: All
Age: 15+
Code: NCT05033288
Recruiting
Feasibility of a Constant Pressure Skin Disk (CPSD) in Enteral Tubes.
for
Gastrostomy
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 22+
Code: NCT03959878
Recruiting
Lead-212 PSV359 Therapy for Patients With Solid Tumors
for
Pancreatic Ductal Adenocarcinoma, Gastric Cancer,
Location: Rochester MN, Madison WI, Omaha NE, Kansas City KS,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06710756
Phase 1, Phase 2, Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Rochester MN, Minneapolis MN, Madison WI, Iowa City IA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase 3, Recruiting
Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
for
Breast Cancer, PALB2-Mutated Breast Carcinoma,
Location: Rochester MN, Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT06488378
Phase 1, Recruiting
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia
for
Coronary Artery Disease, Myocardial Infarction
Location: Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT05111288
Recruiting
Registry of Patients Prescribed Anticoagulation
for
Acute Deep Vein Thrombosis, Acute Pulmonary Embolism
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT03504007
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Rochester MN, Peoria IL, Ann Arbor MI, Toledo OH,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701656
Phase 2, Recruiting
Study of Lunresertib Alone or in Combination With RP-3500 or Zedoresertib (Debio 0123) in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Rochester MN, Grand Rapids MI, St Louis MO, Toronto,
Sponsor: Debiopharm International SA
Sex: All
Age: 12+
Code: NCT04855656
Phase 1, Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens
for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Rochester MN, Iowa City IA, Omaha NE, Chicago IL,